Keywords: science, grants, eisai, rights, sigma, agonist, sa4503

M

Article | 17 March 2008

Print This

M's Science Corp has granted rights to fellow Japanese drugmaker Eisai under an option agreement for SA4503, a novel sigma ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in